{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:49:23Z","timestamp":1791262163291,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The prevalence of transsexualism is thought to differ among socio-geographic backgrounds, and little is known about its prevalence in Japan. Polycystic ovary syndrome (PCOS), which is known to be associated with insulin resistance and metabolic syndrome, is often seen in female-to-male (FTM) transsexual patients. Consequently, detection of PCOS is an important part of health care for these individuals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>The purpose of this study was to assess the prevalence of transsexuality in Japan, as well as the incidences of PCOS and insulin resistance among Japanese FTM transsexual patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>One hundred four male-to-female (MTF) and 238 FTM Japanese transsexual patients were studied. Medical histories, including histories of menstrual cycling and hormone treatment, were taken. To exclude other diseases, such as congenital adrenal hyperplasia and hormone-secreting tumors, thorough medical assessments, including transvaginal or transrectal ultrasonography and measurement of serum hormone levels and insulin resistance indexes, were performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>The diagnosis of PCOS was based on the Rotterdam 2003 criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Based on demographic statistics, the prevalences of MTF and FTM transsexuality are about 3.97 and 8.20 per 100,000 people, respectively, making the MTF-to-FTM ratio about 1:2. Of the FTM transsexual patients studied, 128 had not taken hormones before their initial assessment (untreated group); the remaining 50 self-administered androgen. Among the untreated group, 32.0% were diagnosed with PCOS, 30.1% were insulin-resistant, and 31.1% showed hypoadiponectinemia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The sex ratio among Japanese transsexuals is different than among Caucasians. PCOS and insulin resistance are common findings in FTM transsexual patients at initial presentation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2011.02252.x","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T03:44:40Z","timestamp":1302234280000},"page":"1686-1693","source":"Crossref","is-referenced-by-count":54,"title":["Distinctive Features of Female-to-Male Transsexualism and Prevalence of Gender Identity Disorder in Japan"],"prefix":"10.1093","volume":"8","author":[{"given":"Tsuyoshi","family":"Baba","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sapporo Medical University , Sapporo ,, Japan"},{"name":"Department of GID Clinic, Sapporo Medical University , Sapporo ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sapporo Medical University , Sapporo ,, Japan"},{"name":"Department of GID Clinic, Sapporo Medical University , Sapporo ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sapporo Medical University , Sapporo ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sapporo Medical University , Sapporo ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Honnma","sequence":"additional","affiliation":[{"name":"Asada Ladies Clinic , Aichi ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of GID Clinic, Sapporo Medical University , Sapporo ,, Japan"},{"name":"Department of Occupational Therapy, Hokkaido Bunkyo University , Eniwa ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Masumori","sequence":"additional","affiliation":[{"name":"Department of GID Clinic, Sapporo Medical University , Sapporo ,, Japan"},{"name":"Department of Urology, Sapporo Medical University , Sapporo ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tousei","family":"Ohmura","sequence":"additional","affiliation":[{"name":"Department of GID Clinic, Sapporo Medical University , Sapporo ,, Japan"},{"name":"First Department of Surgery, Sapporo Medical University , Sapporo ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Kiya","sequence":"additional","affiliation":[{"name":"Ena Ladies Clinic , Ishikari ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Kamiya Ladies Clinic , Sapporo ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoiki","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Eve Women's Clinic , Sapporo ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sapporo Medical University , Sapporo ,, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"key":"2024032521501661400_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eurpsy.2006.10.002","article-title":"Prevalence and demography of transsexualism in Belgium","volume":"22","author":"De Cuypere","year":"2007","journal-title":"Eur Psychiatry"},{"key":"2024032521501661400_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"19","author":"The Rotterdam ESHERE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"2024032521501661400_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"The Rotterdam ESHERE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"2024032521501661400_bb0025","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"2024032521501661400_bb0030","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/humrep\/den263","article-title":"Cardiometabolic risk in polycystic ovary syndrome: A comparison of different approaches to defining the metabolic syndrome","volume":"23","author":"Cussons","year":"2008","journal-title":"Hum Reprod"},{"key":"2024032521501661400_bb0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2265.1993.tb01013.x","article-title":"Polycystic ovaries are a common finding in untreated female to male transsexuals","volume":"38","author":"Balen","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032521501661400_bb0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0306-4530(97)00033-4","article-title":"A higher rate of hyperandrogenic disorders in female-to-male transsexuals","volume":"22","author":"Bosinski","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"2024032521501661400_bb0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/humrep\/del474","article-title":"Association between polycystic ovary syndrome and female-to-male transsexuality","volume":"22","author":"Baba","year":"2007","journal-title":"Hum Reprod"},{"key":"2024032521501661400_bb0050","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1210\/jc.2007-2808","article-title":"Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals","volume":"93","author":"Mueller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032521501661400_bb0055","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"2024032521501661400_bb0060","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032521501661400_bb0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00006254-199906000-00024","article-title":"Polycystic ovary syndrome: Clinical perspectives and management","volume":"54","author":"Futterweit","year":"1999","journal-title":"Obstet Gynecol Surv"},{"key":"2024032521501661400_bb0070","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentration of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024032521501661400_bb0075","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032521501661400_bb0080","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1210\/jcem.87.6.8550","article-title":"Decreased plasma adiponectin concentrations in women with dyslipidemia","volume":"87","author":"Matsubara","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032521501661400_bb0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-2002-34785","article-title":"Adiponectin\u2014its role in metabolism and beyond","volume":"34","author":"Stefan","year":"2002","journal-title":"Horm Metab Res"},{"key":"2024032521501661400_bb0090","article-title":"The ICD-10 classification of mental and behavioral disorders. Clinical descriptions and diagnostic guidelines","author":"World Health Organization","year":"1992"},{"key":"2024032521501661400_bb0095","article-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV)","author":"American Psychiatric Press","year":"1994"},{"key":"2024032521501661400_bb0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2024032521501661400_bb0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2169\/internalmedicine.43.453","article-title":"Associations among lifestyle status, serum adiponectin level and insulin resistance","volume":"43","author":"Yokoyama","year":"2004","journal-title":"Intern Med"},{"key":"2024032521501661400_bb0110","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: Toward a rational approach","author":"Zawadzki","year":"1992","journal-title":"Polycystic ovary syndrome"},{"key":"2024032521501661400_bb0115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"Task force on the phenotype of the polycystic ovary syndrome of the Androgen Excess and PCOS society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"2024032521501661400_bb0120","first-page":"220","article-title":"Sociodemographic profile of transsexual patients","volume":"21","author":"Duisin","year":"2009","journal-title":"Psychiatr Danub"},{"key":"2024032521501661400_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0306-4530(92)90054-B","article-title":"Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia","volume":"17","author":"Dittmann","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"2024032521501661400_bb0130","first-page":"357","article-title":"Androgen excess fetal programming of female reproduction: A developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum Reprod"},{"key":"2024032521501661400_bb0135","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/brain\/awn276","article-title":"A sex difference in the hypothalamic uncinate nucleus: Relationship to gender identity","volume":"131","author":"Garcia-Falgueras","year":"2008","journal-title":"Brain"},{"key":"2024032521501661400_bb0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/GRF.0b013e31803057ed","article-title":"Pregnancy considerations in women with polycystic ovary syndrome","volume":"50","author":"Legro","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"2024032521501661400_bb0145","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women","volume":"66","author":"Alvarez-Blasco","year":"2006","journal-title":"Arch Intern Med"},{"key":"2024032521501661400_bb0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1743-6109.2007.00681.x","article-title":"Is physical examination required before prescribing hormones to patients with gender dysphoria?","volume":"5","author":"Vardi","year":"2008","journal-title":"J Sex Med"},{"issue":"1","key":"2024032521501661400_bb0155","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1291\/hypres.19.SupplementI_S1","article-title":"Insulin resistance and hypertension in Japanese","volume":"19","author":"Iimura","year":"1996","journal-title":"Hypertens Res"},{"key":"2024032521501661400_bb0160","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00041433-200312000-00003","article-title":"Obesity, adiponectin and vascular inflammatory disease","volume":"14","author":"Ouchi","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"2024032521501661400_bb0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2008.01.007","article-title":"Role of adiponectin in regulating ovarian theca and granulosa cell function","volume":"284","author":"Lagaly","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"2024032521501661400_bb0170","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1745-7262.2006.00204.x","article-title":"Testosterone decreases adiponectin levels in female to male transsexuals","volume":"8","author":"Berra","year":"2006","journal-title":"Asian J Androl"},{"key":"2024032521501661400_bb0175","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2164\/jandrol.108.004952","article-title":"Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments","volume":"29","author":"Resmini","year":"2008","journal-title":"J Androl"},{"key":"2024032521501661400_bb0180","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1210\/jc.2004-0303","article-title":"Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels","volume":"89","author":"Bottner","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032521501661400_bb0185","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2265.2004.02007.x","article-title":"Serum adiponectin levels in hypogonadal males: Influence of testosterone replacement therapy","volume":"60","author":"Lanfranco","year":"2004","journal-title":"Clin Endocrinol"},{"key":"2024032521501661400_bb0190","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.fertnstert.2010.03.048","article-title":"The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome","volume":"94","author":"Cupisti","year":"2010","journal-title":"Fertil Steril"},{"key":"2024032521501661400_bb0195","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024032521501661400_bb0200","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1111\/j.1743-6109.2010.01962.x","article-title":"Safety of physiological testosterone therapy in women: Lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy","volume":"7","author":"Traish","year":"2010","journal-title":"J Sex Med"},{"key":"2024032521501661400_bb0205","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/j.1743-6109.2009.01380.x","article-title":"Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals","volume":"6","author":"Perrone","year":"2009","journal-title":"J Sex Med"},{"key":"2024032521501661400_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03632.x","article-title":"Effects of sex steroid use on cardiovascular risk in transsexual individuals: A systematic review and meta-analysis","volume":"72","author":"Elamin","year":"2010","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515335530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515335530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/6\/1686\/47245322\/jsm_8_6_1686.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/6\/1686\/47245322\/jsm_8_6_1686.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T22:01:28Z","timestamp":1711404088000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/8\/6\/1686\/6843948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,1]]},"published-print":{"date-parts":[[2011,6,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02252.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,6]]},"published":{"date-parts":[[2011,6,1]]}}}